QR Kod

Mesothelin expression remodeled the immune-matrix tumor microenvironment predicting the risk of death in patients with malignant pleural mesothelioma

BackgroundThe combination of immunobiological agents with immune checkpoint proteins is a promising treatment for malignant pleural mesothelioma (MPM). Mesothelin and anti-PD-L1 antibody-drug conjugates specifically target malignant neoplastic cells, inhibit the migration and invasion of neoplastic...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Aline Nery Qualiotto, Camila Machado Baldavira, Marcelo Balancin, Alexandre Ab’Saber, Teresa Takagaki, Vera Luiza Capelozzi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2023-10-01
Seri Bilgileri:Frontiers in Immunology
Konular:
malignant mesothelioma
mesothelin
PD-L1
immune cells
computational quantification
immunohistochemistry
Online Erişim:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268927/full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller